46 Sessions  PREVNEXT

  • Main Hall
    1F
  • Sakura
    1F
  • Annex 1
    1F
  • Annex 2
    1F
  • Room A
    2F
  • Room B1
    2F
  • Room B2
    2F
  • Room C2
    1F
  • Room D
    1F
  • Room E
    1F
  • Gala Dinner
    Prince Hotel
8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00 22:00

11:15

AdamF.Cohen{COHENADAMF.}____Plenary Lecture 4
Why TGN1412 was safe and BIA 10-2474 dangerous. The case for mechanism based drug development|1|2|EijiUchida{UCHIDAEIJI}____

S05

Plenary Lecture 4
Why TGN1412 was safe...

08:30

RobertB.Innis{INNISROBERTB.}____Cutting Edge Lecture 26
Linking Positron Emission Tomography to Therapeutic Trials in Dementia and in Depression|1|26|TetsuyaSuhara{SUHARATETSUYA}____

S34

Cutting Edge Lecture 26
Link...

08:30

CurtisD.Klaassen{KLAASSENCURTISD.}____Cutting Edge Lecture 27
Effects of the Microbiome on Xenobiotic Processing Genes|1|27|BarbaraF.Hales{HALESBARBARAF.}____

S35

Cutting Edge Lecture 27
Effe...

08:30

ShimonSakaguchi{SAKAGUCHISHIMON}____Cutting Edge Lecture 28
Molecular targeting of regulatory T cells for control of immune responses|1|21|MasatakaMajima{MAJIMAMASATAKA}____

S36

Cutting Edge Lecture 28
Mole...

15:05

MasatakaKuwana{KUWANAMASATAKA}____Cutting Edge Lecture 29
Biologics versus small molecules in treatment of systemic autoimmune diseases|1|21|ShinichiKawai{KAWAISHINICHI}____

S37

Cutting Edge Lecture 29
Biol...

08:30

TakashiKadowaki{KADOWAKITAKASHI}____Cutting Edge Lecture 30
The adiponectin receptor: Physiology and pharmacology|1|28|MasatoKasuga{KASUGAMASATO}____

S38

Cutting Edge Lecture 30
The ...

08:30

TakaoShimizu{SHIMIZUTAKAO}____Cutting Edge Lecture 31
Phospholipid metabolism in health and disease|1|29|TakehikoYokomizo{YOKOMIZOTAKEHIKO}____

S39

Cutting Edge Lecture 31
Phos...

08:30

MinGooLee{LEEMINGOO}____Cutting Edge Lecture 32
Unconventional Secretion of Transmembrane Protein|1|9|YoshikatsuKanai{KANAIYOSHIKATSU}____

S40

Cutting Edge Lecture 32
Unco...

08:30

SamuelH.H.Chan{CHANSAMUELH.H.}____Cutting Edge Lecture 33
Differential clinical impacts of oxidative stress and nitrosative stress: Therapeutic implications|1|9|NaohikoAnzai{ANZAINAOHIKO}____

S41

Cutting Edge Lecture 33
Diff...

09:25

NobutakaHattori{HATTORINOBUTAKA}|BrianJ.Spencer{SPENCERBRIANJ.}|NigelH.Greig{GREIGNIGELH.}|MasatoHasegawa{HASEGAWAMASATO}____Symposium 54
Alpha-synuclein in Parkinson's disease|1|3|MasahiroNomoto{NOMOTOMASAHIRO}|NigelH.Greig{GREIGNIGELH.}____

S98

Symposium 54
Alpha-synuclein in Parkinson's disease

16:10

LauraMusazzi{MUSAZZILAURA}|JordanMarrocco{MARROCCOJORDAN}|JiroKasahara{KASAHARAJIRO}|Hye-SunKim{KIMHYE-SUN}____Symposium 55
Mechanisms of maladaptive plasticity in animal models of neuropsychiatric disorders|1|3|MaurizioPopoli{POPOLIMAURIZIO}|LauraMusazzi{MUSAZZILAURA}____PaoloTornese{TORNESEPAOLO}|NathalieSala{SALANATHALIE}|DanielaBonini{BONINIDANIELA}|TizianaBonifacino{BONIFACINOTIZIANA}|MarcoMilanese{MILANESEMARCO}|LucaLaVia{LAVIALUCA}|GianbattistaBonanno{BONANNOGIANBATTISTA}|AlessandroBarbon{BARBONALESSANDRO}|MaurizioPopoli{POPOLIMAURIZIO}|KihwanLee{LEEKIHWAN}|HyunjuKim{KIMHYUNJU}|Moon-JeongChang{CHANGMOON-JEONG}

S99

Symposium 55
Mechanisms of maladaptive plasticity in animal mode...

09:25

ShinichiroUeda{UEDASHINICHIRO}|YukihitoHigashi{HIGASHIYUKIHITO}|KimTran{TRANKIM}|NeerajDhaun(Bean){DHAUN(BEAN)NEERAJ}____Symposium 56
Pharmacology and Clinical Pharmacology about Inflammation and the Development of Atherosclerosis|1|4|YukihitoHigashi{HIGASHIYUKIHITO}|KimTran{TRANKIM}____

S100

Symposium 56
Pharmacology and Clinical Pharmacology about Inflam...

16:10

JasonYuan{YUANJASON}|AyakoMakino{MAKINOAYAKO}|CarolineSunggip{SUNGGIPCAROLINE}|HisaoYamamura{YAMAMURAHISAO}____Symposium 57
Therapeutic strategy to enhance intrinsic resistance in cardiovascular system|1|4|MotohiroNishida{NISHIDAMOTOHIRO}|JasonYuan{YUANJASON}____ShanshanSong{SONGSHANSHAN}|ShaneG.Carr{CARRSHANEG.}|KimberlyM.Mcdermott{MCDERMOTTKIMBERLYM.}|MariselaRodriguez{RODRIGUEZMARISELA}|AleksandraBabicheva{BABICHEVAALEKSANDRA}|AngelaBalistrieri{BALISTRIERIANGELA}|RamonJ.Ayon{AYONRAMONJ.}|JianWang{WANGJIAN}|AyakoMakino{MAKINOAYAKO}|RuiSi{SIRUI}|QianZhang{ZHANGQIAN}|MakikoWatanabe{WATANABEMAKIKO}|MotohiroNishida{NISHIDAMOTOHIRO}|AkiyukiNishimura{NISHIMURAAKIYUKI}|TakuroNumagaTomita{TOMITATAKURONUMAGA}|HitoshiKurose{KUROSEHITOSHI}|BernardRobaye{ROBAYEBERNARD}|YoshiakiSuzuki{SUZUKIYOSHIAKI}|YujiImaizumi{IMAIZUMIYUJI}

S101

Symposium 57
Therapeutic strategy to enhance intrinsic resistanc...

09:25

JaeGookShin{SHINJAEGOOK}|KathyGiacomini{GIACOMINIKATHY}|MikiNakajima{NAKAJIMAMIKI}|IchiroIeiri{IEIRIICHIRO}____Symposium 58
Pharmacogenomics in drug therapy; Future perspective, next generation of pharmacogenomics|1|25|IchiroIeiri{IEIRIICHIRO}|Jae-GookShin{SHINJAE-GOOK}____

S102

Symposium 58
Pharmacogenomics in drug therapy; Future perspectiv...

16:10

ChristineR.Keenan{KEENANCHRISTINER.}|ElaineT.Alarid{ALARIDELAINET.}|ShuTingChen{CHENSHUTING}|InKyeomKim{KIMINKYEOM}____Symposium 59
Nuclear receptors as novel therapeutic targets|1|25|UyDongSohn{SOHNUYDONG}|KoshiHashimoto{HASHIMOTOKOSHI}____KyleHelzer{HELZERKYLE}|NataliaSolodin{SOLODINNATALIA}|ElizabethShana{SHANAELIZABETH}|KatsuhikoShirahige{SHIRAHIGEKATSUHIKO}

S103

Symposium 59
Nuclear receptors as novel therapeutic targets

09:25

YukihikoSugimoto{SUGIMOTOYUKIHIKO}|RaymondN.DuBois{DUBOISRAYMONDN.}|TimothyHla{HLATIMOTHY}|HidekiAmano{AMANOHIDEKI}____Symposium 60
Roles of Bioactive Lipids in Inflammatory Diseases|1|21|MasatakaMajima{MAJIMAMASATAKA}|RaymondN.DuBois{DUBOISRAYMONDN.}____MasatakaMajima{MAJIMAMASATAKA}

S104

Symposium 60
Roles of Bioactive Lipids in Inflammatory Diseases

16:10

YeongWookSong{SONGYEONGWOOK}|ToshihiroNanki{NANKITOSHIHIRO}|KunihiroYamaoka{YAMAOKAKUNIHIRO}|KevinL.Winthrop{WINTHROPKEVINL.}____Symposium 61
Advances in molecular targeting therapy for rheumatoid arthritis|1|21|MasayoshiHarigai{HARIGAIMASAYOSHI}|KevinL.Winthrop{WINTHROPKEVINL.}____

S105

Symposium 61
Advances in molecular targeting therapy for rheumat...

09:25

PäiviMariaPaldánius{PALDÁNIUSPÄIVIMARIA}|UmutOzcan{OZCANUMUT}|MasatoIwabu{IWABUMASATO}|KohjiroUeki{UEKIKOHJIRO}____Symposium 62
Novel Strategies for Treatment of Obesity-induced Diabetes|Novartis Pharma K.K. Medical Division|1|28|KohjiroUeki{UEKIKOHJIRO}|UmutOzcan{OZCANUMUT}____ToshimasaYamauchi{YAMAUCHITOSHIMASA}|MikiOkada-Iwabu{OKADA-IWABUMIKI}|TakashiKadowaki{KADOWAKITAKASHI}

S106

Symposium 62
Novel Strategies for Treatment of Obesity-induced D...

Sponsor:Novartis Pharma K.K. Medical Division

16:10

You-LinTain{TAINYOU-LIN}|TohruMinamino{MINAMINOTOHRU}|JulieY.H.Chan{CHANJULIEY.H.}____Symposium 63
Role of mitochondria and oxidative stress in metabolic syndrome|1|28|JulieY.H.Chan{CHANJULIEY.H.}|You-LinTain{TAINYOU-LIN}____JulieY.H.Chan{CHANJULIEY.H.}|Yung-MeiChao{CHAOYUNG-MEI}|KayLhWu{WUKAYLH}

S107

Symposium 63
Role of mitochondria and oxidative stress in metabo...

09:25

AlastairG.Stewart{STEWARTALASTAIRG.}|ArataAzuma{AZUMAARATA}|CliveP.Page{PAGECLIVEP.}|W.S.FredWong{WONGW.S.FRED}____Symposium 64
Novel Therapeutic Strategies for Respiratory Diseases|1|29|W.S.FredWong{WONGW.S.FRED}|AlastairG.Stewart{STEWARTALASTAIRG.}____ChristineRKeenan{KEENANCHRISTINER}|MeinaLi{LIMEINA}|ConnieXia{XIACONNIE}|WupengLiao{LIAOWUPENG}

S108

Symposium 64
Novel Therapeutic Strategies for Respiratory Diseases

16:10

NaokiYoshimura{YOSHIMURANAOKI}|RussChess-Williams{CHESS-WILLIAMSRUSS}|TakahikoMitsui{MITSUITAKAHIKO}|NaokiWada{WADANAOKI}____Symposium 65
Lower Urinary Tract Dysfunction Update: New Insight into Pharmacological Mechanisms1|1|7|HidehiroKakizaki{KAKIZAKIHIDEHIRO}|MasayukiTakeda{TAKEDAMASAYUKI}____MasayukiTakeda{TAKEDAMASAYUKI}|HidehiroKakizaki{KAKIZAKIHIDEHIRO}

S109

Symposium 65
Lower Urinary Tract Dysfunction Update: New Insight...

09:25

GregoryR.Monteith{MONTEITHGREGORYR.}|NataliaPrevarskaya{PREVARSKAYANATALIA}|NagomiKurebayashi{KUREBAYASHINAGOMI}|SamRobinson{ROBINSONSAM}____Symposium 66
Molecular pharmacology focused studies of calcium permeable ion channels: Identifying new pharmacological targets and therapies|1|9|MasamitsuIino{IINOMASAMITSU}|SamRobinson{ROBINSONSAM}____DmitroGordienko{GORDIENKODMITRO}|GabrielBidaux{BIDAUXGABRIEL}|CharlotteDubois{DUBOISCHARLOTTE}|FabienVandenAbeele{ABEELEFABIENVANDEN}|Lehen'kyiV'yacheslav{LEHEN'KYIV'YACHESLAV}|LoicLemonnier{LEMONNIERLOIC}|RomanSkryma{SKRYMAROMAN}|IrinaVetter{VETTERIRINA}|JenniferR.Deuis{DEUISJENNIFERR.}|KathleenYin{YINKATHLEEN}|EivindUndheim{UNDHEIMEIVIND}|NicholasCasewell{CASEWELLNICHOLAS}

S110

Symposium 66
Molecular pharmacology focused studies of calcium p...

16:10

YasuteruUrano{URANOYASUTERU}|Wen-YihI.Tseng{TSENGWEN-YIHI.}|VictorL.Villemagne{VILLEMAGNEVICTORL.}____Symposium 67
Multidisciplinary Approach on Molecular Bio-imaging from Basic to Clinical Pharmacological Studies|1|26|KazuhikoYanai{YANAIKAZUHIKO}|SamuelH.H.Chan{CHANSAMUELH.H.}____

S111

Symposium 67
Multidisciplinary Approach on Molecular Bio-imaging...

09:25

RosalindeMasereeuw{MASEREEUWROSALINDE}|HiroyukiKusuhara{KUSUHARAHIROYUKI}|SanjayK.Nigam{NIGAMSANJAYK.}|AleksandraGaletin{GALETINALEKSANDRA}____Symposium 68
The prediction of renal drug transport: A story with many tales|1|24|RosalindeMasereeuw{MASEREEUWROSALINDE}|HiroyukiKusuhara{KUSUHARAHIROYUKI}____

S112

Symposium 68
The prediction of renal drug transport: A story wit...

16:10

MichaelSpedding{SPEDDINGMICHAEL}|DanielHoyer{HOYERDANIEL}|XiupingChen{CHENXIUPING}|GuanhuaDu{DUGUANHUA}____Symposium 69
Pharmacological investigation in new drug discovery|1|20|GuanhuaDu{DUGUANHUA}|MichaelSpedding{SPEDDINGMICHAEL}____WenSun{SUNWEN}|HongweiGao{GAOHONGWEI}|Jin-JianLu{LUJIN-JIAN}|LianhuaFang{FANGLIANHUA}|YuehuaWang{WANGYUEHUA}|LiZhang{ZHANGLI}|YangLv{LVYANG}|LidaDu{DULIDA}|AilinLiu{LIUAILIN}|JuntianZhang{ZHANGJUNTIAN}

S113

Symposium 69
Pharmacological investigation in new drug discovery

09:25

TakuroSugai{SUGAITAKURO}|NorioYasui-Furukori{YASUI-FURUKORINORIO}|CherrieA.Galletly{GALLETLYCHERRIEA}____Symposium 70
Shortened life span in patients with schizophrenia: Life style related problems and clinical pharmacology of antipsychotics|1|3|ToshiyukiSomeya{SOMEYATOSHIYUKI}|KazutakaShimoda{SHIMODAKAZUTAKA}____YutaroSuzuki{SUZUKIYUTARO}|ManabuYamazaki{YAMAZAKIMANABU}|KazutakaShimoda{SHIMODAKAZUTAKA}|TakaoMori{MORITAKAO}|HiroshiMatsuda{MATSUDAHIROSHI}|NorioSugawara{SUGAWARANORIO}|NorioYasui-Furukori{YASUI-FURUKORINORIO}|KurefuOkamoto{OKAMOTOKUREFU}|YujiOzeki{OZEKIYUJI}|ToyoakiSagae{SAGAETOYOAKI}|ToshiyukiSomeya{SOMEYATOSHIYUKI}|TakuroSugai{SUGAITAKURO}

S114

Symposium 70
Shortened life span in patients with schizophrenia:...

16:10

LudmilaFilaretova{FILARETOVALUDMILA}|ShinFukudo{FUKUDOSHIN}|JohnF.Cryan{CRYANJOHNF.}|NathalieVergnolle{VERGNOLLENATHALIE}____Symposium 71
Brain-Gut Axis|1|3|NathalieVergnolle{VERGNOLLENATHALIE}|LudmilaFilaretova{FILARETOVALUDMILA}____

S115

Symposium 71
Brain-Gut Axis

08:15

MartinC.Michel{MICHELMARTINC.}____IUPHAR Guideline Draft
Discussion of draft IUPHAR guidelines on design, analysis and reporting of studies in experimental pharmacology|1|1|MichaelSpedding{SPEDDINGMICHAEL}____AntonBespalov{BESPALOVANTON}|MichaelJCurtis{CURTISMICHAELJ}|MalcomMcleod{MCLEODMALCOM}|HarveyMotulsky{MOTULSKYHARVEY}

S08

IUPHAR Guideline Draft
Discussion of d...

13:50

GregoryTCollins{COLLINSGREGORYT}|EeVonMoo{MOOEEVON}|ErikSDietrichs{DIETRICHSERIKS}|KentoKitada{KITADAKENTO}|MaiKawazoe{KAWAZOEMAI}|MiJeongHeo{HEOMIJEONG}|YueFei{FEIYUE}|Tong-FeiLi{LITONG-FEI}|DayanaAbboud{ABBOUDDAYANA}|NishantRai{RAINISHANT}|BirgitCaspar{CASPARBIRGIT}____IUPHAR Young Investigator Award Competition|1|1|S.J.Enna{ENNAS.J.}____BrendaMGannon{GANNONBRENDAM}|MichaelHBaumann{BAUMANNMICHAELH}|AgnieszkaSulima{SULIMAAGNIESZKA}|KennerCRice{RICEKENNERC}|PatrickMSexton{SEXTONPATRICKM}|ArthurChristopoulos{CHRISTOPOULOSARTHUR}|CelineValant{VALANTCELINE}|KarenMcglynn{MCGLYNNKAREN}|AndrewAllan{ALLANANDREW}|AdamConnolly{CONNOLLYADAM}|MartinBishop{BISHOPMARTIN}|FrancisBurton{BURTONFRANCIS}|RachelMyles{MYLESRACHEL}|TorkjelTveita{TVEITATORKJEL}|GodfreyLSmith{SMITHGODFREYL}|YahuaZhang{ZHANGYAHUA}|JanetDKlein{KLEINJANETD}|AdrianaMarton{MARTONADRIANA}|SteffenDaub{DAUBSTEFFEN}|AkiraNishiyama{NISHIYAMAAKIRA}|FriedrichCLuft{LUFTFRIEDRICHC}|JeffMSands{SANDSJEFFM}|JensTitze{TITZEJENS}|KaichiKaneko{KANEKOKAICHI}|ShinichiKawai{KAWAISHINICHI}|ToshihiroNanki{NANKITOSHIHIRO}|TaeHyunKim{KIMTAEHYUN}|SangGeonKim{KIMSANGGEON}|Man-FungTsoi{TSOIMAN-FUNG}|CyrusRKumana{KUMANACYRUSR}|TommyTsangCheung{CHEUNGTOMMYTSANG}|BernardManYungCheung{CHEUNGBERNARDMANYUNG}|XiaoChen{CHENXIAO}|AdrianDaly{DALYADRIAN}|PatriciaMolina{MOLINAPATRICIA}|NadineDupuis{DUPUISNADINE}|CelineLaschet{LASCHETCELINE}|PierreGeubelle{GEUBELLEPIERRE}|BernardPirotte{PIROTTEBERNARD}|AlbertBeckers{BECKERSALBERT}|JulienHanson{HANSONJULIEN}|KavitaGulati{GULATIKAVITA}|ArunabhaRay{RAYARUNABHA}|LeighAStoddart{STODDARTLEIGHA}|JoelleGoulding{GOULDINGJOELLE}|StephenJBriddon{BRIDDONSTEPHENJ}|StephenJHill{HILLSTEPHENJ}

O36

IUPHAR Young Investigator Award Competition

12:30

NaokiWatanabe{WATANABENAOKI}____JPS Frontiers Session 5
Insights from real-time monitoring of molecular behavior responding to drugs and physical forces|1|1|ChihiroYabe-Nishimura{YABE-NISHIMURACHIHIRO}____

K4

JPS Frontiers Session 5
Insights from ...

12:30

TomokoHasunuma{HASUNUMATOMOKO}____JSCPT Frontiers Session 4
Absence of ethnic differences in the pharmacokinetics of several drugs among three east Asian populations and Caucasians|1|1|JunkoSato{SATOJUNKO}____

K9

JSCPT Frontiers Session 4
Absence of e...

12:30

FrancisChan{CHANFRANCIS}____Luncheon Seminar 12
Use of acid suppressants in patients receiving anti-thrombotic therapy|EA Pharma Co., Ltd.|1|1|TakahisaFuruta{FURUTATAKAHISA}____

LS12

Luncheon Seminar 12
Use of acid suppre...

Sponsor:EA Pharma Co., Ltd.

13:50

ShuntaroUchida{UCHIDASHUNTARO}|JuntianZhang{ZHANGJUNTIAN}|García-PupoL{LGARCÍA-PUPO}|SalvatoreCuzzocrea{CUZZOCREASALVATORE}|DengliWang{WANGDENGLI}____Oral session 23
Neuroscience 5|1|1|TakeshiSakurai{SAKURAITAKESHI}|MasahiroNishibori{NISHIBORIMASAHIRO}____YokoTIrukayama{IRUKAYAMAYOKOT}|YasuhiroOgawa{OGAWAYASUHIRO}|TakutoYamaguchi{YAMAGUCHITAKUTO}|YukikoIshikawa{ISHIKAWAYUKIKO}|ShingoSoya{SOYASHINGO}|TsuyoshiSaito{SAITOTSUYOSHI}|HiroshiNagase{NAGASEHIROSHI}|MasashiYanagisawa{YANAGISAWAMASASHI}|TakeshiSakurai{SAKURAITAKESHI}|GuanhuaDu{DUGUANHUA}|ShifengChu{CHUSHIFENG}|SánchezJR{JRSÁNCHEZ}|RatmanD{DRATMAN}|Pérez-NovoC{CPÉREZ-NOVO}|DeclerckK{KDECLERCK}|DeBosscherK{KDEBOSSCHER}|MarkakisMn{MNMARKAKIS}|BeemsterG{GBEEMSTER}|ZaldoA{AZALDO}|FigueredoYNuñez{YNUÑEZFIGUEREDO}|Delgado-HernándezR{RDELGADO-HERNÁNDEZ}|VandenBergheW{WVANDENBERGHE}|MichelaCampolo{CAMPOLOMICHELA}|EmanuelaEsposito{ESPOSITOEMANUELA}|GiovannaCasili{CASILIGIOVANNA}|TimothyDoyle{DOYLETIMOTHY}|DanielaSalvemini{SALVEMINIDANIELA}|KeyueLiu{LIUKEYUE}|HidenoriWake{WAKEHIDENORI}|KiyoshiTeshigawara{TESHIGAWARAKIYOSHI}|ShujiMori{MORISHUJI}|MasahiroNishibori{NISHIBORIMASAHIRO}

O23

Oral session 23
Neuroscience 5

14:50

AndreaHuwiler{HUWILERANDREA}|FumikazuSano{SANOFUMIKAZU}|KhaledSAbd-Elrahman{ABD-ELRAHMANKHALEDS}|LuisPereiradeAlmeida{PEREIRADEALMEIDALUIS}|AkikoKobayashi{KOBAYASHIAKIKO}____Oral session 24
Neuroscience 6|1|1|MasatoshiHagiwara{HAGIWARAMASATOSHI}____FaikImeri{IMERIFAIK}|BiseraStepanovska{STEPANOVSKABISERA}|AleksandraZivkovic{ZIVKOVICALEKSANDRA}|JosefPfeilschifter{PFEILSCHIFTERJOSEF}|BrittaEngelhardt{ENGELHARDTBRITTA}|HolgerStark{STARKHOLGER}|EijiShigetomi{SHIGETOMIEIJI}|SchuichiKoizumi{KOIZUMISCHUICHI}|HideakiKanemura{KANEMURAHIDEAKI}|KatsuhikoMikoshiba{MIKOSHIBAKATSUHIKO}|MasaoAihara{AIHARAMASAO}|AlisonHamilton{HAMILTONALISON}|ShaunessyHutchinson{HUTCHINSONSHAUNESSY}|StephenS.G.Ferguson{FERGUSONSTEPHENS.G.}|RuiJorgeNobre{NOBRERUIJORGE}|JoanaSaraiva{SARAIVAJOANA}|CleliaFusco{FUSCOCLELIA}|SusanaPaixao{PAIXAOSUSANA}|MagdaSantana{SANTANAMAGDA}|JoaoCastelhano{CASTELHANOJOAO}|JoseSereno{SERENOJOSE}|MiguelCastelo-Branco{CASTELO-BRANCOMIGUEL}|MiguelSena-Esteves{SENA-ESTEVESMIGUEL}|TomonariAwaya{AWAYATOMONARI}|IsaoKii{KIIISAO}|YutoSumida{SUMIDAYUTO}|YukikoOkuno{OKUNOYUKIKO}|KeikoWanezaki{WANEZAKIKEIKO}|SuguruYoshida{YOSHIDASUGURU}|HaruhisaInoue{INOUEHARUHISA}|TakamitsuHosoya{HOSOYATAKAMITSU}|MasatoshiHagiwara{HAGIWARAMASATOSHI}

O24

Oral session 24
Neuroscience 6

13:50

JorgTaubel{TAUBELJORG}|MelissaVChan{CHANMELISSAV}|MaurizioSessa{SESSAMAURIZIO}|PavelMadonov{MADONOVPAVEL}|GerdMikus{MIKUSGERD}____Oral session 25
Cardiovascular System 5: Clinical Study|1|1|YukihitoHigashi{HIGASHIYUKIHITO}|NeerajDhaun(Bean){DHAUN(BEAN)NEERAJ}____JonathanBowen{BOWENJONATHAN}|DanielaCimmaruta{CIMMARUTADANIELA}|DilshatDjumanov{DJUMANOVDILSHAT}|UlrikeLorch{LORCHULRIKE}|SimonCoates{COATESSIMON}|GeorgFerber{FERBERGEORG}|TemoBarwari{BARWARITEMO}|JenniferEHuffman{HUFFMANJENNIFERE}|PaulCArmstrong{ARMSTRONGPAULC}|PeterSanter{SANTERPETER}|StefanKiechl{KIECHLSTEFAN}|JohannWilleit{WILLEITJOHANN}|ManuelMayr{MAYRMANUEL}|AndrewDJohnson{JOHNSONANDREWD}|TimothyDWarner{WARNERTIMOTHYD}|AnnamariaMascolo{MASCOLOANNAMARIA}|RikkeNMortensen{MORTENSENRIKKEN}|MikkelPAndersen{ANDERSENMIKKELP}|GiuseppeMcRosano{ROSANOGIUSEPPEMC}|AnnalisaCapuano{CAPUANOANNALISA}|FrancescoRossi{ROSSIFRANCESCO}|GunnarGislason{GISLASONGUNNAR}|HenrikEnghusen-Poulsen{ENGHUSEN-POULSENHENRIK}|ChristianTorp-Pedersen{TORP-PEDERSENCHRISTIAN}|AleksandrDygai{DYGAIALEKSANDR}|VadimZhdanov{ZHDANOVVADIM}|StanislavLeontyev{LEONTYEVSTANISLAV}|SergeyZotov{ZOTOVSERGEY}|MaksimUfimtsev{UFIMTSEVMAKSIM}|SvetlanaMishenina{MISHENINASVETLANA}|DmitriiKinsht{KINSHTDMITRII}|MichaelFBoettcher{BOETTCHERMICHAELF}|Hans-DirkDuengen{DUENGENHANS-DIRK}|FrankDonath{DONATHFRANK}|NikosWerner{WERNERNIKOS}|PetraAThuermann{THUERMANNPETRAA}|MahirKarakas{KARAKASMAHIR}|BorisWeimann{WEIMANNBORIS}|TanjaKoch{KOCHTANJA}|CorinaBecker{BECKERCORINA}

O25

Oral session 25
Cardiovascular System ...

14:50

HusseinNRubaiy{RUBAIYHUSSEINN}|MinYang{YANGMIN}|YujiImaizumi{IMAIZUMIYUJI}|ShoichiMatsuda{MATSUDASHOICHI}|MargaretRCunningham{CUNNINGHAMMARGARETR}____Oral session 26
Cardiovascular System 6: Ion Channels/Signaling|1|1|KimioSatoh{SATOHKIMIO}|AyakoMakino{MAKINOAYAKO}____MathiasChristmann{CHRISTMANNMATHIAS}|KatsuhikoMuraki{MURAKIKATSUHIKO}|DavidJBeech{BEECHDAVIDJ}|WenqiangGan{GANWENQIANG}|TiegangLi{LITIEGANG}|KatsuhitoMatsuki{MATSUKIKATSUHITO}|YoshiakiSuzuki{SUZUKIYOSHIAKI}|HisaoYamamura{YAMAMURAHISAO}|SusumuOhya{OHYASUSUMU}|HiroshiTakeshima{TAKESHIMAHIROSHI}|MichioNakaya{NAKAYAMICHIO}|ShioriKomiya{KOMIYASHIORI}|AkiomiNagasaka{NAGASAKAAKIOMI}|HitoshiKurose{KUROSEHITOSHI}

O26

Oral session 26
Cardiovascular System ...

13:50

HuaWang{WANGHUA}|TakuyaNotomi{NOTOMITAKUYA}|AtsuoKuramasu{KURAMASUATSUO}____Oral session 27
Immunology, Inflammation and Bone Metabolism 2|1|1|RyujiKoike{KOIKERYUJI}|HidetoAkama{AKAMAHIDETO}____JiaoQu{QUJIAO}|ZhihuiZhang{ZHANGZHIHUI}|ChengZheng{ZHENGCHENG}|PanpanZhang{ZHANGPANPAN}|RongSi{SIRONG}|YuhanChao{CHAOYUHAN}|LiuchengLi{LILIUCHENG}|LiangXu{XULIANG}|JianGao{GAOJIAN}|MiyukiKuno{KUNOMIYUKI}|AkikoHiyama{HIYAMAAKIKO}|TadashigeNozaki{NOZAKITADASHIGE}|KiyoshiOhura{OHURAKIYOSHI}|YoichiEzura{EZURAYOICHI}|MasakiNoda{NODAMASAKI}|MakotoInui{INUIMAKOTO}

O27

Oral session 27
Immunology, Inflammati...

13:50

Ming-JaiSu{SUMING-JAI}|ShuainanLiu{LIUSHUAINAN}|AlessandraBitto{BITTOALESSANDRA}|JoelA.Bosha{BOSHAJOELA.}____Oral session 28
Metabolism and Diabetes 2|1|1|JoelBosha{BOSHAJOEL}____Chen-YenTsai{TSAICHEN-YEN}|Chi-TunRuan{RUANCHI-TUN}|Chi-HuanYeh{YEHCHI-HUAN}|Chao-MinHsu{HSUCHAO-MIN}|Sheng-FaTask{TASKSHENG-FA}|Shoes-ShengLee{LEESHOES-SHENG}|YueWang{WANGYUE}|QuanLiu{LIUQUAN}|RongcuiLi{LIRONGCUI}|YiHuan{HUANYI}|ZhufangShen{SHENZHUFANG}|FedericaMannino{MANNINOFEDERICA}|NatashaIrrera{IRRERANATASHA}|GiovanniPallio{PALLIOGIOVANNI}|DomenicaAltavilla{ALTAVILLADOMENICA}|FrancescoSquadrito{SQUADRITOFRANCESCO}|AruhO.Anagah{ANAGAHARUHO.}|IsaacUAsuzu{ASUZUISAACU}

O28

Oral session 28
Metabolism and Diabetes 2

14:50

SaoriMukaida{MUKAIDASAORI}|DonytraA.Wardhana{WARDHANADONYTRAA.}|AkiraIshii{ISHIIAKIRA}|SuleimanAl-Sabah{AL-SABAHSULEIMAN}|PatrickNOkechukwu{OKECHUKWUPATRICKN}____Oral session 29
Metabolism and Diabetes 3|1|1|SaoriMukaida{MUKAIDASAORI}|AkiraIshii{ISHIIAKIRA}____MasaakiSato{SATOMASAAKI}|MichelleLHalls{HALLSMICHELLEL}|MartinaKocan{KOCANMARTINA}|BronwynAEvans{EVANSBRONWYNA}|RogerJSummers{SUMMERSROGERJ}|ToreBengtsson{BENGTSSONTORE}|DanaSHutchinson{HUTCHINSONDANAS}|KojiIkeda{IKEDAKOJI}|DhiteB.Nugroho{NUGROHODHITEB.}|AgianJ.Barinda{BARINDAAGIANJ.}|KikidR.Qurania{QURANIAKIKIDR.}|KeikoYagi{YAGIKEIKO}|Ken-IchiHirata{HIRATAKEN-ICHI}|NoriakiEmoto{EMOTONORIAKI}|GoroKatsuura{KATSUURAGORO}|HirotakaImamaki{IMAMAKIHIROTAKA}|HiroyukiKimura{KIMURAHIROYUKI}|KeitaP.Mori{MORIKEITAP.}|HidekiYokoi{YOKOIHIDEKI}|KousakuOhinata{OHINATAKOUSAKU}|JunichiTsuchida{TSUCHIDAJUNICHI}|KazuwaNakao{NAKAOKAZUWA}|MotokoYanagita{YANAGITAMOTOKO}|MasashiMukoyama{MUKOYAMAMASASHI}|KiyoshiMori{MORIKIYOSHI}|MoritzBunemann{BUNEMANNMORITZ}|CorneliusKrasel{KRASELCORNELIUS}|YeeYingWong{WONGYEEYING}|SophiaOEkeuku{EKEUKUSOPHIAO}|FarahnazAmini{AMINIFARAHNAZ}

O29

Oral session 29
Metabolism and Diabetes 3

13:50

BahireKalfaoglu{KALFAOGLUBAHIRE}|JensSchlossmann{SCHLOSSMANNJENS}|BaoxueYang{YANGBAOXUE}|DaisukeYamazaki{YAMAZAKIDAISUKE}|MaryAnnSuico{SUICOMARYANN}____Oral session 30
Nephrology and Urology 1|1|1|NaohikoAnzai{ANZAINAOHIKO}____TomMckinnon{MCKINNONTOM}|CharlesD.Pusey{PUSEYCHARLESD.}|FrederickW.K.Tam{TAMFREDERICKW.K.}|TheresaH.Page{PAGETHERESAH.}|VeronikaHerrmann{HERRMANNVERONIKA}|ElisabethSchinner{SCHINNERELISABETH}|KentoKitada{KITADAKENTO}|NorihikoMorisawa{MORISAWANORIHIKO}|YoshihideFujisawa{FUJISAWAYOSHIHIDE}|DaisukeNakano{NAKANODAISUKE}|HirofumiHitomi{HITOMIHIROFUMI}|JensTitze{TITZEJENS}|AkiraNishiyama{NISHIYAMAAKIRA}|KoheiOmachi{OMACHIKOHEI}|MisatoKamura{KAMURAMISATO}|KeisukeTeramoto{TERAMOTOKEISUKE}|HarukaKojima{KOJIMAHARUKA}|TsubasaYokota{YOKOTATSUBASA}|ShotaKaseda{KASEDASHOTA}|JunKuwazuru{KUWAZURUJUN}|TsuyoshiShuto{SHUTOTSUYOSHI}|HirofumiKai{KAIHIROFUMI}

O30

Oral session 30
Nephrology and Urology 1

14:50

ShogoShimizu{SHIMIZUSHOGO}|ZaneStromberga{STROMBERGAZANE}|AshleeMCaldwell{CALDWELLASHLEEM}|ChitaranjanMahapatra{MAHAPATRACHITARANJAN}|BusraErtas{ERTASBUSRA}____Oral session 31
Nephrology and Urology 2|1|1|HikaruHashitani{HASHITANIHIKARU}|RussChess-Williams{CHESS-WILLIAMSRUSS}____TakahiroShimizu{SHIMIZUTAKAHIRO}|KumikoNakamura{NAKAMURAKUMIKO}|YouichirouHigashi{HIGASHIYOUICHIROU}|TakaakiAratake{ARATAKETAKAAKI}|SuoZou{ZOUSUO}|MotoakiSaito{SAITOMOTOAKI}|RussChess-Williams{CHESS-WILLIAMSRUSS}|ChristianMoro{MOROCHRISTIAN}|LukeGrundy{GRUNDYLUKE}|AndelainErickson{ERICKSONANDELAIN}|SoniaGarcia-Caraballo{GARCIA-CARABALLOSONIA}|GrigoriRychkov{RYCHKOVGRIGORI}|StuartBrierley{BRIERLEYSTUART}|RohitManchanda{MANCHANDAROHIT}|KlBrain{BRAINKL}|MuhammetEminCam{CAMMUHAMMETEMIN}|ZarifeNigarOzdemir-Kumral{OZDEMIR-KUMRALZARIFENIGAR}|SilaYildiz{YILDIZSILA}|OzgeCevik{CEVIKOZGE}|BerrakYegen{YEGENBERRAK}|GokselSener{SENERGOKSEL}

O31

Oral session 31
Nephrology and Urology 2

13:50

NurdianaNurdiana{NURDIANANURDIANA}|MasatoKatsuyama{KATSUYAMAMASATO}|ChooHockTan{TANCHOOHOCK}|EmmanuelC.Chinedu{CHINEDUEMMANUELC.}____Oral session 32
Toxicology|1|1|MasatoKatsuyama{KATSUYAMAMASATO}|ChooHockTan{TANCHOOHOCK}____EvaNurAzizah{AZIZAHEVANUR}|PoppyFarantiaSaputri{SAPUTRIPOPPYFARANTIA}|MokhamadNooryanto{NOORYANTOMOKHAMAD}|KusnarmanKeman{KEMANKUSNARMAN}|BambangSetiawan{SETIAWANBAMBANG}|ChihiroYabe-Nishimura{YABE-NISHIMURACHIHIRO}|KinYingWong{WONGKINYING}|KaeYiTan{TANKAEYI}|SiMuiSim{SIMSIMUI}|NgetHongTan{TANNGETHONG}|MercyO.Ogbaji{OGBAJIMERCYO.}|OlugbengaAkinola{AKINOLAOLUGBENGA}|GraceOGbotosho{GBOTOSHOGRACEO}

O32

Oral session 32
Toxicology

14:50

AbdurRauf{RAUFABDUR}|YasuhitoShimada{SHIMADAYASUHITO}|JinchengChen{CHENJINCHENG}|PeterKovacs{KOVACSPETER}|DiadelisRemirez{REMIREZDIADELIS}____Oral session 33
Natural Medicine and Traditional East Asian Medicines 2|1|1|Jing-YanHan{HANJING-YAN}|KinzoMatsumoto{MATSUMOTOKINZO}____AbdulLatif{LATIFABDUL}|HirokoNakayama{NAKAYAMAHIROKO}|LiqingZang{ZANGLIQING}|MasahiroTerasawa{TERASAWAMASAHIRO}|KaoruNishiura{NISHIURAKAORU}|KoichiMatsuda{MATSUDAKOICHI}|CharlesToombs{TOOMBSCHARLES}|ChrisLangdon{LANGDONCHRIS}|NorihiroNishimura{NISHIMURANORIHIRO}|DennisChang{CHANGDENNIS}|JunguoRen{RENJUNGUO}|ChengrenLin{LINCHENGREN}|BensoussanAlan{ALANBENSOUSSAN}|JianxunLiu{LIUJIANXUN}|ZoltanSzilvassy{SZILVASSYZOLTAN}|SandorSomodi{SOMODISANDOR}|ZoltanSzabo{SZABOZOLTAN}|BelaJuhasz{JUHASZBELA}

O33

Oral session 33
Natural Medicine and T...

13:50

HiromiSato{SATOHIROMI}|GraziaP.Nicchia{NICCHIAGRAZIAP.}|EvaKmonickova{KMONICKOVAEVA}|YuFukuda{FUKUDAYU}|JohnsonStanslas{STANSLASJOHNSON}____Oral session 34
Cancer 2|1|1|AtsushiOhtsu{OHTSUATSUSHI}|GraziaPaolaNicchia{NICCHIAGRAZIAPAOLA}____AyakaShimizu{SHIMIZUAYAKA}|MiakiUzu{UZUMIAKI}|KoichiUeno{UENOKOICHI}|AkihiroHisaka{HISAKAAKIHIRO}|LauraSimone{SIMONELAURA}|MariaG.Mola{MOLAMARIAG.}|FrancescoPisani{PISANIFRANCESCO}|ConcettaD.Gargano{GARGANOCONCETTAD.}|AntonioFrigeri{FRIGERIANTONIO}|MariaSvelto{SVELTOMARIA}|SilvieRimpelova{RIMPELOVASILVIE}|MichalJurasek{JURASEKMICHAL}|PetrDzubak{DZUBAKPETR}|DavidSedlak{SEDLAKDAVID}|ZdenekZidek{ZIDEKZDENEK}|JurajHarmatha{HARMATHAJURAJ}|PavelDrasar{DRASARPAVEL}|AliceAllcock{ALLCOCKALICE}|JuwinaWijaya{WIJAYAJUWINA}|TomokaGose{GOSETOMOKA}|WenweiLin{LINWENWEI}|TaoshengChen{CHENTAOSHENG}|JohnD.Schuetz{SCHUETZJOHND.}|ShunYingQuah{QUAHSHUNYING}|MichelleSTan{TANMICHELLES}|YuanHanTeh{TEHYUANHAN}|PranKDeb{DEBPRANK}|SreenivasaRSagineedu{SAGINEEDUSREENIVASAR}

O34

Oral session 34
Cancer 2

14:50

MasahikoAjiro{AJIROMASAHIKO}|Seung-TaekLee{LEESEUNG-TAEK}|YapingTu{TUYAPING}|ShimpeiIKubota{KUBOTASHIMPEII}|OscarDellaPasqua{DELLAPASQUAOSCAR}____Oral session 35
Cancer 3|1|1|OscarDellaPasqua{DELLAPASQUAOSCAR}|MasahikoAjiro{AJIROMASAHIKO}____HiroyukiSakai{SAKAIHIROYUKI}|HiroshiOnogi{ONOGIHIROSHI}|TakashiNomura{NOMURATAKASHI}|KenjiKabashima{KABASHIMAKENJI}|MasatoshiHagiwara{HAGIWARAMASATOSHI}|Won-SikShin{SHINWON-SIK}|YanXie{XIEYAN}|PeterW.Abel{ABELPETERW.}|TaotaoWei{WEITAOTAO}|XuLuo{LUOXU}|KeiTakahashi{TAKAHASHIKEI}|JunNishida{NISHIDAJUN}|ShogoEhata{EHATASHOGO}|KazukiTainaka{TAINAKAKAZUKI}|UedaRHiroki{HIROKIUEDAR}|KoheiMiyazono{MIYAZONOKOHEI}|SeanOosterholt{OOSTERHOLTSEAN}|AnnaLisaScardovi{SCARDOVIANNALISA}|RobertoTonelli{TONELLIROBERTO}

O35

Oral session 35
Cancer 3

19:00

-____Gala Dinner|1|1|-____

TABLE042

Gala Dinner

Advanced Search